You may have seen some stories about how drug manufacturers have been exercising “restraint” in keeping their 2018 price increases under 10%. This makes me sick. These companies are raising prices with absolutely no cost justification, this is purely generating higher profits. They should be pilloried, not lauded.
Wishing all my readers a warm, memorable holiday season. As always, enjoy your family and friends. Focus on your blessings, accept your trials. And believe in your strength.
The nation’s largest post-acute care provider, Kindred, is being purchased for $4.1 billion in a complex transaction. Humana will end up owning about 40% of a new company that has Kindred’s home health and hospice business. Two PE firms will purchase the remaining 60% of that business and all of Kindred’s long-term hospital business.